Immunohistochemistry Control sections for IHC

Control sections for IHC and IF applications Presented by Vector Laboratories Speakers: Craig Pow, Ph.D., and Byron Hsu, M.S. Content How do you know the tissue staining you are reporting is accurate? Use of control sections in Immunohistochemistry (IHC) and Immunofluorescence (IF) a...

Read more

Immunofluorescence Maximizing Signal Retention

Maximizing Signal Retention in IF Applications Presented by Vector Laboratories Speakers: Craig Pow, Ph.D., and Byron Hsu, M.S. Content Low signal and loss of signal frustrate investigators as these issues are often encountered when performing immunofluorescence (IF) assays. Learn techniq...

Read more

Immunohistochemistry Troubleshooting background

Troubleshooting background in IHC and IF applications Presented by Vector Laboratories Speakers: Craig Pow, Ph.D., and Byron Hsu, M.S. Content Although the causes of non-specific background staining in Immunohistochemistry (IHC) and Immunofluorescence (IF) applications may differ slightly...

Read more

Targeting Glycosylated PD-L1 Enhance Patients’ Anti-Cancer Immune Response

Targeting Glycosylated PD-L1 to Enhance Patients’ Anti-Cancer Immune Response Presented by GeneTex Speaker: Chia-Wei Li, PhD, MD Anderson Cancer Center, Texas Content GeneTex’s webinar explored the development of more effective cancer therapies, with particular focus on enh...

Read more

Pancreatic Cancer An Insidious and Stubborn Foe

Pancreatic cancer is the third leading cause of cancer-related death in the United States. With a predicted five-year relative survival rate of 9%, pancreatic cancer continues to be clinically challenging due to its resistance to even the most aggressive combinations of surgery, chemotherapy, and radiotherapy. Because of indistinct symptoms and the absence of reliable diagnostic biomarkers, diagnoses ar...

Read more

COVID-19 Enzymes in COVID-19 Inflammation

Enzymes catalyze a number of important biological reactions. In the context of SARS-CoV-2, they are vital for viral entry and replication. Learn more about the key enzymes utilized by this virus and potential therapeutics to block them.

Read more

COVID-19 Bioactivity Evaluation of Neutralizing Antibodies In Vitro

This webinar discusses the approaches used to screen for SARS-CoV-2 (2019-nCoV) neutralizing antibodies and evaluate their bioactivity in vitro. Speaker: Dong Li, Ph.D., Senior Scientist at Sino Biological Inc.

Read more

Ehrlichia Canis In-Clinic Diagnosis

Diagnosis of the tick-borne rickettsia infection, caused by Ehrlichia canis can be challenging due to its different phases and multiple clinical manifestations. In this webinar, you’ll confront this challenge together with Dr. Netta by focusing on the clinical aspects of the disease in general practice, and on how to make the most of common in-clinic diagnostic protocols in conjunction with Serology and PCR....

Read more

COVID-19 Single-Cell Biology of Barrier Tissues

In this talk, Dr. Ordovas-Montañes will discuss recent studies utilizing single-cell genomics to comprehensively map the cell types, subsets, and states that compose human barrier tissues. He will present findings related to health and disease in the nasal and intestinal mucosa and recent work to understand the potential cellular targets of SARS-CoV-2 in these tissues. He will also share challeng...

Read more

Cell Viability Lysosome Function, Cathepsin Activity, and Cell Viability Techniques

At ICT, we are on a mission to help cure disease and we do that by providing better assays to study lysosomal functionality, cell viability, and cathepsins. Watch this webinar to understand the role of lysosomes and cathepsins, and how they impact cell viability, apoptosis, autophagy, mitosis, and mitochondrial function. What will you learn?

Read more